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Abstract
Objective: The aim of this study is to investigate the effects of pregabalin on the behavior of 
UDWVXQGHUWKHLQÁXHQFHRINHWDPLQHDQ10'$UHFHSWRUDQWDJRQLVWWKDWPLPLFVWKHV\PSWRPVRI
schizophrenia. Methods:5DWVZHUHLQMHFWHGZLWKVDOLQHRUPJNJNHWDPLQHLQWUDSHULWRQHDOO\







to treat psychotic symptoms.
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Efeitos da pregabalina sobre alterações comportamentais induzidas pela cetamina 
em ratos
Resumo
Objetivo: O presente estudo tem como objetivo investigar os efeitos da pregabalina sobre as 







pela cetamina. Conclusão: Este é o primeiro estudo que investiga os efeitos da pregabalina em um 
PRGHORDQLPDOGHSVLFRVH1RVVRVUHVXOWDGRVLQGLFDPTXHDOWHUDo}HVFRPSRUWDPHQWDLVLQGX]LGDV
SHODFHWDPLQDHPUDWRVSRGHPVHUUHYHUWLGDVDSyVXVRGDSUHJDEDOLQDRTXHVXJHUHXPSRVVtYHO





Outras áreas das 
neurociências e 




despite the advances in pharmacological and non-pharma-
FRORJLFDODSSURDFKHV7KHGLIÀFXOW\OLHVLQWKHKHWHURJHQHLW\
RIWKHFRQGLWLRQH[SUHVVHGLQWKHVXEMHFWLYHDQGFRPSOH[
QDWXUHRI LWV V\PSWRPVDQGWKH ODFNRIDFRPSUHKHQVLYH
model to explain its pathophysiology. 
The dopamine hypothesis for the pathophysiology of schizo-
SKUHQLDLVLQVXIÀFLHQWWRH[SODLQWKHGLVRUGHUFRPSOHWHO\7KH
LQHIIHFWLYHQHVVRI' UHFHSWRUEORFNDGH LQ WKH WUHDWPHQWRI
QHJDWLYHV\PSWRPVIRUH[DPSOHKLJKOLJKWVWKHQHHGWRVHDUFK
for other explanations and mechanisms that could be involved 
in schizophrenia. The glutamatergic hypothesis of schizophre-
QLDSRVWXODWHV WKDW WKHK\SRIXQFWLRQRI10'$JOXWDPDWHUJLF
receptors in cortical-limbic areas could lead to alterations in 
interneuron transmission that would exacerbate dopaminergic 
function.1&XPXODWLYHGDWDLQWKHOLWHUDWXUHDOVRVXJJHVWDUROH
RI*$%$LQVFKL]RSKUHQLD One of the explanations suggests 
WKDWDGHFUHDVHLQLQWHUQHXURQ*$%$HUJLFDFWLYLW\LQGXFHGE\
WKHODFNRIDFWLYDWLRQGXHWR10'$K\SRIXQFWLRQFRXOGOHDGWR
an increased activity of excitatory glutamatergic transmission 
in cortical-limbic areas.3+RZHYHU EHQ]RGLD]HSLQHVZKLFK
LQFUHDVH*$%$HUJLFDFWLYLW\DUHQRWSDUWLFXODUO\HIIHFWLYH LQ
treatment of schizophrenia.47KHUHIRUH VWUDWHJLHV WKDWXVH




approved for the treatment of generalized anxiety disorder in 
the European Union.5 
Two previous reports described the use of pregabalin in 
schizophrenic patients as an add-on treatment for schizo-
phrenia-related anxiety. The current study was aimed at 
testing the hypothesis that pregabalin itself can have anti-
SV\FKRWLFSURSHUWLHV:LWKWKDWLQPLQGZHUHLQYHVWLJDWHG
LWVHIIHFWVRQ WKHEHKDYLRURI UDWVXQGHU WKH LQÁXHQFHRI









$QLPDOV DQG WKH %UD]LOLDQ 6RFLHW\ IRU 1HXURVFLHQFH DQG












Animal model of psychosis
7KH DQLPDOV ZHUH LQMHFWHG ZLWK VDOLQH RU PJNJ RI
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DFRPSXWHUE\WKHVRIWZDUH2SHQ6RXUFHYHUVLRQ,QWHUEDVH
 $FWLYLW\ 0RQLWRU ² ,QVLJKW /DERUDWRU\ (TXLSPHQW
5LEHLUmR3UHWR63
Stereotypy
This parameter was analyzed simultaneously with locomo-
tor activity. Stereotypy is considered by the software as an 
unstable movement; any time repetitive movements are 









The effects of ketamine on the behavior of rats






The effects of pregabalin on ketamine-induced 
hyperlocomotion
)LUVW WKHHIIHFWVRISUHJDEDOLQRQEDVDO ORFRPRWLRQZHUH
evaluated in groups that received saline solution prior to drug 











The effects of pregabalin on ketamine-induced 
stereotypy




RQ WKH ORFRPRWLRQRI UDWV DOWKRXJKQRW UHGXFLQJJHQHUDO
PRWRUDFWLYLW\ZKHQDGPLQLVWHUHGDORQHLQIDFWWKHKLJK
GRVHRISUHJDEDOLQLQFUHDVHGORFRPRWRUDFWLYLW\RQLWVRZQ
which suggests that this reduction was not secondary to mo-
tor impairment. 
$QLPDOPRGHOV RI SV\FKRVLV WKDW XVH 10'$ UHFHSWRU
DQWDJRQLVWV WR LQGXFH EHKDYLRUDO FKDQJHV OLNH K\SHUORFR-
motion and stereotypy have often been used to assess the 
pharmacological effects of different candidate substances 
IRU WKH WUHDWPHQW RI V\PSWRPV LQ VFKL]RSKUHQLD with 
some evidence of parallels between those pharmacologically 
LQGXFHGEHKDYLRUDODOWHUDWLRQVLQUDWVE\GHFUHDVHVLQ10'$
function and behavioral alterations present in schizophrenia. 
)RUH[DPSOHLWKDVEHHQSURSRVHGWKDWLQFUHDVHGORFRPRWRU





derive from complex effects on neurotransmission through 
LWVELQGLQJWRWKHŞšW\SHDQGVXEXQLWVRIYROWDJHJDWHG
FDOFLXPFKDQQHOVDVZHOODVE\LWVDFWLRQVLQWKHJOXWDPDWH
*$%$F\FOH12 Our data indicate that pregabalin somehow 
HQKDQFHV10'$UHFHSWRUIXQFWLRQVLQFHNHWDPLQHLQGXFHG
EHKDYLRUDODOWHUDWLRQVDUHH[SODLQHGE\LWV10'$UHFHSWRU
EORFNDGH +RZHYHU WKLV HQKDQFHPHQW RI 10'$ UHFHSWRU
mediated action after pregabalin use is not through direct 
DFWLRQDWWKH10'$UHFHSWRUVLQFHWKLVGUXJGRHVQRWLQWHU-






SUHJDEDOLQ XVH GXH WR WKH*$%$HUJLF DFWLRQ RI WKLV GUXJ
,QDGGLWLRQ WKLV*$%$HUJLFDFWLRQPLJKWEH OLQNHG WR WKH








One possible explanation for this increase in basal locomo-
WLRQE\SUHJDEDOLQZKLFKKDVDOUHDG\EHHQGHVFULEHGZLWK
GLD]HSDPLQPLFHLVWKDWWKHDQ[LRO\WLFHIIHFWRISUHJDEDOLQ
- which was previously described in the literature5 - could 
increase the observed basal locomotion at higher doses.15 
+RZHYHUSDUDGR[LFDOO\WKLVKLJKGRVHUHYHUVHVWKHK\SHUOR-
FRPRWLRQREVHUYHGZLWKNHWDPLQHVXJJHVWLQJWKDWVRPHWKLQJ
other than an anxiolytic effect of pregabalin is involved in 
WKLVSDUWLFXODUGUXJGUXJLQWHUDFWLRQDWWKHSUHVHQWDFOHDU
explanation is not available.
Pregabalin at both doses decreased the stereotypy be-
KDYLRULQGXFHGE\NHWDPLQHWROHYHOVQHDUWKHFRQWUROJURXS
)LJXUH % EXW WKH UHGXFWLRQZDV QRW TXLWH VWDWLVWLFDOO\
VLJQLÀFDQWDWHLWKHUGRVHVS 0RUHFRPSUHKHQVLYH
dose and time studies should be done before we can suggest 
that pregabalin may be useful for treating the stereotypy 
LQGXFHGE\NHWDPLQH
,Q FRQFOXVLRQ RXU UHVXOWV LQGLFDWH WKDW WKH ORFRPRWRU
FKDQJHVLQGXFHGE\NHWDPLQHLQUDWVFDQEHUHYHUVHGZLWK
WKHXVHRISUHJDEDOLQVXJJHVWLQJSRWHQWLDORISUHJDEDOLQDV
an add-on drug option for schizophrenia. Two previous clini-
cal reports described the use of pregabalin in schizophrenic 

































Figure 1A (IIHFWV RI SUHJDEDOLQ 3*.HW 3*.HW RQ K\SHUORFRPRWLRQ













patients as an add-on treatment for schizophrenia-related 
DQ[LHW\EXW WRRXUNQRZOHGJH WKLV LV WKHÀUVW VWXG\ WR
investigate the direct effects of pregabalin using an animal 
model of psychosis. 
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